COVID-19 infection could reveal by Stroke scans, research

COVID-19 infection could reveal by Stroke scans,research

New research from King’s College London has found that COVID-19 could also be diagnosed on an equivalent emergency scan intended to diagnose stroke. The findings have important implications within the management of patients presenting with suspected stroke through early identification of COVID-19. In a paper published today within the American Journal of Neuroradiology, study lead and Senior Lecturer in Neuroimaging at King’s College London, Dr. Tom Booth said the emergency scans captured images of the top of the lungs where a fluffiness known as ‘ground-glass opacification’ allowed COVID-19 to be diagnosed.

COVID-19 infection could reveal by Stroke scans, research

225 patients were examined from three London Hyper-Acute Stroke Units. The emergency stroke scan consisted of computed tomography (CT) of the head and neck blood vessels. Dr. Booth said the results show that when the team saw these changes in the top of the lungs during the emergency scan, they were able to reliably and accurately diagnose COVID-19 and the changes also predicted increased mortality.

“This is particularly relevant given the limitations of currently available Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) reverse transcriptase-polymerase chain reaction (RT-PCR) testing as it takes time to complete the test and sometimes it is inaccurate,” Dr. Booth said. “Additionally, our data have prognostic information given the increased mortality in those with lung changes shown in our cohort. These are useful results because the changes are simple for radiologists and other doctors to see.

This is “free information” from a scan intended for another purpose yet extremely valuable,” added Dr. Booth. Primarily, the findings allow earlier selection of the appropriate level of personal protective equipment (PPE) and attendant staff numbers, triage to appropriate inpatient ward settings, self-isolation, and contact tracing. 

Arjun Vedant

Arjun Vedant is the founder of and young Indian science journalist who is quite popular in the field of science reporting, he has great working experience with Pharma and Biotech companies like Alkem Lab, Lupin Ltd.

Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

Researchers found the new method to defeating Chronic Myelogenous Leukemia

Sat Sep 19 , 2020
Researchers have identified a new mathod to defeating Chronic Myelogenous Leukemia, which tends to affect older adults, even within the face of resistance to existing drugs. The new findings were published on September 17th in Nature Communications. Almost all patients with chronic myelogenous leukemia, or CML, have a faulty, cancer-causing […]
new study chronic myelogenous leukemia